4-methoxycarbonylphenylboronic acid CAS NO.99768-12-4

Product Name: 4-methoxycarbonylphenylboronic acid            

English synonyms: rarechema hpb0115; P - (methoxycarbonyl) phenylboronicacid; methyl4-boronobenzoate; akosbrn-0122; 4-methoxycarbonylbenzoniacid; 4-methoxycarboxychemical book nylphenylboronicacid; 4-carboxycarbonyl phenyl bionicacid; methyl4-borobonzoate4 - (methoxycarbonyl) phenylboronicacid            

CAS No.: 99768-12-4            

Molecular formula: c8h9bo4            

Molecular weight: 179.97            

Appearance: white to light yellow crystal powder            

Purity: > 98% HPLC            

Melting point: 197-200 ° C            

Storage temperature and shelf life: sealed storage, away from oxidants            

Introduction: blueberry anthocyanins; blueberry anthocyanins; natural antioxidants. Ingredients: derivatives of flavonoids and flavanone. Properties: reddish brown to dark brown powder, lump or liquid, with a little special flavor. Slightly soluble in water. Source: the water-soluble extract from Vaccinium uliginosum L., a plant of Rhododendron family. Anthocyanins are widely distributed in flowers, fruits and rhizomes of plants. They are the main chromogenic components in plants and belong to flavonoid chemical Book compounds. Anthocyanins have a variety of physiological functions. They can regulate capillary permeability, maintain cell integrity, and have strong antioxidant function. Further studies found that anthocyanins can promote the synthesis of rhodopsin, prevent thrombosis and arteriosclerosis, anthocyanins exist as glycosides in the natural state, and molecular knot            Application: 4-methoxycarbonylphenylboronic acid is an organic synthesis intermediate and a pharmaceutical intermediate, which can be used in the laboratory organic synthesis process and pharmaceutical research and development process.

Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization.  Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.

It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.